Answers are grounded in this paper and cite their sources.
Reviews guidelines and clinical controversies in ventilator-associated pneumonia prevention in intensive care units, highlighting challenges in bedside management.
Ventilator associated pneumonia continues to be a cause of significant morbidity and mortality in critically ill patients. VAP is the second most common nosocomial infection in intensive care units, affecting 27% of all critically ill patients. In the last ten years, American, Canadian, European and Irish scientific societies have documented their evidence based guidelines on the prevention of VAP. The intent of this article is to provide concise and practical knowledge for the bedside clinicians in ICU to aid in VAP prevention efforts. It also focuses on the controversies with regard to diagnostic tools and approaches, treatment plans and prevention strategies.
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: